Bangalore, Mar 12, 2010: Bilcare Global Clinical Supplies, a clinical trial services provider will open its second unit in The Elvicta Industrial Estate, Crickhowell, Wales, UK. The new unit will add 30,000 sq.ft. and double the company's European capacity to package, store and distribute clinical supplies in ambient, refrigerated and frozen conditions.

Bilcare – a global company headquartered in India – established its Crickhowell site in 2006 when it purchased DHP. The Bilcare Global Clinical Supplies facility at Crickhowell is contributing to a nascent pharmaceutical 'cluster' of companies in UK.

Mr Mohan Bhandari, Chairman and Managing Director of Bilcare Limited, said, “With the drug discovery program leading to potential new drugs becoming more complex, the need to clinically test drug efficacy and safety in diverse population groups across multiple geographic regions is becoming a crucial necessity. This necessity has lead Bilcare to expand and open new facilities in the US, Europe and Asia.”

In conjunction with the expansion, Bilcare Research specializes in primary packaging for pharmaceutical products and security technology such as nonClonable. Based on modular architecture, nonClonable enhances customer safety, improves supply chain efficiency, reduces inventory levels, and improves customer relationship management. Speaking on this new and innovative technology, Dr Praful Naik, Chief Scientific Officer, Bilcare, said, “This technology can help to strengthen the secure pedigree of CTM globally across clinical sites and provide multiple business outcomes like effective and authentic management of returns, reconciliation and destruction.”